Invesco S&P International Developed Quality ETF

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IDHQ and other ETFs, options, and stocks.

About IDHQ

IDHQ tracks an index of large- and mid-cap stocks from developed markets ex-US, selected by fundamental metrics. Stocks are weighted by these factors, scaled by market-cap. 

Index-Tracked
S&P Quality Develop xUS Large Mid NR USD
Index-TrackedS&P Quality Develop xUS Large Mid NR USD
Category
Foreign Large Growth
CategoryForeign Large Growth
Number of holdings
210
Number of holdings210
Inception Date
Jun 13, 2007
Inception DateJun 13, 2007

What's in this fund

Sectors

As of September 12, 2025
Industrials19.11%
Financial Services15.96%
Healthcare15.40%
Consumer Cyclical13.05%
Technology12.99%
Consumer Defensive11.28%
Basic Materials4.78%
Communication Services3.69%
Utilities2.03%
Energy1.59%
Real Estate0.12%

Top 10 Holdings (30.91% of total assets)

As of September 12, 2025
NameSymbol% Assets
ASML Holding NVASML (XAMS)5.04%
Novartis AG Registered SharesNOVN (XSWX)3.98%
Nestle SANESN (XSWX)3.59%
AstraZeneca PLCAZN (XLON)3.36%
Roche Holding AGROG (XSWX)3.21%
Unilever PLCULVR (XLON)2.73%
BHP Group LtdBHP (XASX)2.57%
Allianz SEALV (XETR)2.23%
ABB LtdABBN (XSWX)2.16%
Airbus SEAIR (XPAR)2.04%

IDHQ Key Statistics

AUM
513.39M
AUM513.39M
Price-Earnings ratio
18.42
Price-Earnings ratio18.42
30-Day yield
2.20
30-Day yield2.20
Average volume
91.80K
Average volume91.80K
High today
$33.69
High today$33.69
Low today
$33.58
Low today$33.58
Open price
$33.58
Open price$33.58
Volume
16.47K
Volume16.47K
52 Week high
$33.82
52 Week high$33.82
52 Week low
$26.61
52 Week low$26.61
Expense ratio
0.29
Expense ratio0.29

Average Annual Return

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted.